PubRank

Michael Fried

Author PubWeight™ 109.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med 2015 3.13
2 Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis. Hepatology 2010 2.48
3 Limited diagnostic value of laryngopharyngeal lesions in patients with gastroesophageal reflux during routine upper gastrointestinal endoscopy. Am J Gastroenterol 2007 2.26
4 Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl 2002 2.25
5 Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment. Clin Gastroenterol Hepatol 2006 2.12
6 Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med 2004 2.11
7 World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 2010 1.82
8 World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis 2010 1.52
9 Role of biological therapy for inflammatory bowel disease in developing countries. Gut 2011 1.51
10 Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol 2010 1.49
11 Endoscopic position control of nasoenteral feeding tubes by transnasal re-endoscopy: a prospective study in intensive care patients. Am J Gastroenterol 2009 1.49
12 Optimized and combined T1 and B1 mapping technique for fast and accurate T1 quantification in contrast-enhanced abdominal MRI. Magn Reson Med 2007 1.48
13 Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1. J Hepatol 2011 1.47
14 Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC Cancer 2013 1.43
15 Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis 2011 1.41
16 Chronic abdominal pain: not always irritable bowel syndrome. Dig Dis Sci 2006 1.39
17 World Gastroenterology Organisation global guidelines on celiac disease. J Clin Gastroenterol 2013 1.29
18 Influence of bolus consistency and position on esophageal high-resolution manometry findings. Dig Dis Sci 2007 1.26
19 Gastric flow and mixing studied using computer simulation. Proc Biol Sci 2004 1.22
20 Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenet Genomics 2011 1.17
21 Cascade colorectal cancer screening guidelines: a global conceptual model. J Clin Gastroenterol 2011 1.16
22 Regional distribution of solute carrier mRNA expression along the human intestinal tract. Drug Metab Dispos 2007 1.15
23 Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One 2013 1.15
24 hPepT1 selectively transports muramyl dipeptide but not Nod1-activating muramyl peptides. Can J Physiol Pharmacol 2006 1.14
25 Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients. Drug Metab Dispos 2009 1.10
26 The effect of macronutrients on gastric volume responses and gastric emptying in humans: A magnetic resonance imaging study. Am J Physiol Gastrointest Liver Physiol 2006 1.09
27 The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma. J Hepatol 2004 1.09
28 Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT. J Clin Ultrasound 2008 1.06
29 Systematic assessment of factors influencing preferences of Crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL). Inflamm Bowel Dis 2011 1.04
30 Effect of meal volume and calorie load on postprandial gastric function and emptying: studies under physiological conditions by combined fiber-optic pressure measurement and MRI. Am J Physiol Gastrointest Liver Physiol 2009 1.04
31 Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha. J Biol Chem 2002 1.02
32 Analysis of risk factors for low bone mineral density in inflammatory bowel disease. Digestion 2006 1.00
33 Gastric motor function and emptying in the right decubitus and seated body position as assessed by magnetic resonance imaging. J Magn Reson Imaging 2006 1.00
34 Characteristics of the esophageal low-pressure zone in healthy volunteers and patients with esophageal symptoms: assessment by high-resolution manometry. Am J Gastroenterol 2008 0.98
35 Quantification of distal antral contractile motility in healthy human stomach with magnetic resonance imaging. J Magn Reson Imaging 2006 0.97
36 Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2012 0.96
37 Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. Am J Physiol Gastrointest Liver Physiol 2003 0.95
38 Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling. Mol Cell Biol 2010 0.94
39 Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency. Am J Gastroenterol 2013 0.94
40 Pharmacologic treatment of constipation: what is new? Curr Opin Pharmacol 2008 0.94
41 The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4 alpha and suppressed by bile acids. Mol Pharmacol 2005 0.94
42 Loss of protein tyrosine phosphatase nonreceptor type 22 regulates interferon-γ-induced signaling in human monocytes. Gastroenterology 2013 0.93
43 Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm Bowel Dis 2014 0.92
44 Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflamm Bowel Dis 2011 0.92
45 Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology 2002 0.92
46 Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers. Hepatology 2013 0.92
47 Interleukin-13 and transforming growth factor β synergise in the pathogenesis of human intestinal fistulae. Gut 2012 0.92
48 Potential role for SNAIL family transcription factors in the etiology of Crohn's disease-associated fistulae. Inflamm Bowel Dis 2010 0.90
49 Altered psychobiological responsiveness in women with irritable bowel syndrome. Psychosom Med 2012 0.90
50 Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver Transpl 2006 0.88
51 Sphingomyelin induces cathepsin D-mediated apoptosis in intestinal epithelial cells and increases inflammation in DSS colitis. Gut 2010 0.88
52 Contrast-enhanced three-dimensional magnetic resonance angiography for visualization of ectopic varices. Dis Colon Rectum 2002 0.88
53 Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy. Inflamm Bowel Dis 2011 0.88
54 Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells. Gut 2010 0.87
55 BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells. J Biol Chem 2011 0.86
56 Fc gamma receptor CD64 modulates the inhibitory activity of infliximab. PLoS One 2012 0.86
57 The physical properties of rectal contents have effects on anorectal continence: insights from a study into the cause of fecal spotting on orlistat. Dis Colon Rectum 2004 0.86
58 Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis 2010 0.86
59 Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagy. PLoS One 2013 0.84
60 Periodontitis and gingivitis in inflammatory bowel disease: a case-control study. Inflamm Bowel Dis 2013 0.84
61 Effects of posture on the physiology of gastric emptying: a magnetic resonance imaging study. Scand J Gastroenterol 2006 0.84
62 Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Inflamm Bowel Dis 2015 0.84
63 Effect of a prebiotic mixture on intestinal comfort and general wellbeing in health. Br J Nutr 2008 0.83
64 Irritable bowel syndrome among a cohort of European travelers to resource-limited destinations. J Travel Med 2011 0.83
65 Transnasal endoscopy for the placement of nasoenteral feeding tubes: does the working length of the endoscope matter? Gastrointest Endosc 2007 0.83
66 Effect on gastric function and symptoms of drinking wine, black tea, or schnapps with a Swiss cheese fondue: randomised controlled crossover trial. BMJ 2010 0.83
67 World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013. J Clin Gastroenterol 2014 0.82
68 Endoscopy for repeatedly ingested sharp foreign bodies in patients with borderline personality disorder: an international survey. Eur J Gastroenterol Hepatol 2012 0.82
69 Activation of protein tyrosine phosphatase non-receptor type 2 by spermidine exerts anti-inflammatory effects in human THP-1 monocytes and in a mouse model of acute colitis. PLoS One 2013 0.82
70 Barostat measurement of rectal compliance and capacity. Dis Colon Rectum 2006 0.81
71 Gastroesophageal junction: structure and function as assessed by using MR imaging. Radiology 2010 0.81
72 Probiotic Escherichia coli Nissle 1917 and commensal E. coli K12 differentially affect the inflammasome in intestinal epithelial cells. Digestion 2014 0.81
73 Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - an open pilot study. J Crohns Colitis 2012 0.81
74 Visualization and quantification of intestinal transit and motor function by real-time tracking of 19F labeled capsules in humans. Magn Reson Med 2011 0.81
75 NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22. J Clin Invest 2016 0.81
76 The presence of more than two index adenomas is the strongest predictor of metachronous colon adenomas. Swiss Med Wkly 2002 0.81
77 G Protein-coupled pH-sensing Receptor OGR1 Is a Regulator of Intestinal Inflammation. Inflamm Bowel Dis 2015 0.80
78 Tegaserod inhibits the serotonin transporter SERT. Digestion 2007 0.80
79 Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland. Digestion 2004 0.80
80 Validation of a golden angle radial sequence (GOLD) for abdominal T1 mapping during free breathing: demonstrating clinical feasibility for quantifying gastric secretion and emptying. J Magn Reson Imaging 2014 0.80
81 Efficacy and safety of botulinum toxin a injection compared with topical nitroglycerin ointment for the treatment of chronic anal fissure: a prospective randomized study. Am J Gastroenterol 2006 0.80
82 The effects of loperamide on continence problems and anorectal function in obese subjects taking orlistat. Dig Dis Sci 2005 0.80
83 Regulation of the expression of chaperone gp96 in macrophages and dendritic cells. PLoS One 2013 0.80
84 Swiss tertiary care center experience challenges the age-cohort effect in Helicobacter pylori infection. J Gastrointestin Liver Dis 2008 0.79
85 Risk factors for repetitive ileocolic resection in patients with Crohn's disease: results of an observational cohort study. Inflamm Bowel Dis 2014 0.79
86 The role for dickkopf-homolog-1 in the pathogenesis of Crohn's disease-associated fistulae. PLoS One 2013 0.79
87 Magnetic resonance imaging for the in vivo evaluation of gastric-retentive tablets. Pharm Res 2003 0.79
88 A role for tumor necrosis factor and bacterial antigens in the pathogenesis of Crohn's disease-associated fistulae. Inflamm Bowel Dis 2013 0.79
89 Fast and optimized T1 mapping technique for the noninvasive quantification of gastric secretion. J Magn Reson Imaging 2008 0.79
90 Effect of ingestion order of the fat component of a solid meal on intragastric fat distribution and gastric emptying assessed by MRI. J Magn Reson Imaging 2005 0.79
91 Lack of transketolase-like (TKTL) 1 aggravates murine experimental colitis. Am J Physiol Gastrointest Liver Physiol 2011 0.78
92 Improved premenstrual syndrome symptoms after NovaSure endometrial ablation. J Minim Invasive Gynecol 2011 0.78
93 Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations. Eur J Clin Pharmacol 2013 0.78
94 A new heterotopic transplant animal model of intestinal fibrosis. Inflamm Bowel Dis 2013 0.78
95 Sphingomyelin and phosphatidylcholine contrarily affect the induction of apoptosis in intestinal epithelial cells. Mol Nutr Food Res 2013 0.78
96 Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis. Eur J Gastroenterol Hepatol 2004 0.78
97 Influence of stapler haemorrhoidectomy on anorectal function and on patients' acceptance. Swiss Med Wkly 2002 0.77
98 Induction or exacerbation of psoriasis in patients with Crohn's disease under treatment with anti-TNF antibodies. Digestion 2014 0.77
99 World Gastroenterology Organisation Global Guidelines Irritable Bowel Syndrome: A Global Perspective Update September 2015. J Clin Gastroenterol 2016 0.77
100 World Gastroenterology Organisation global guidelines on obesity. J Clin Gastroenterol 2012 0.77
101 Determinants of fecal continence in healthy, continent subjects: a comprehensive analysis by anal manometry, rectal barostat and a stool substitute retention test. Digestion 2010 0.77
102 Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience. Eur J Gastroenterol Hepatol 2016 0.76
103 World gastroenterology organisation global guidelines: dysphagia--global guidelines and cascades update September 2014. J Clin Gastroenterol 2015 0.76
104 Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids 2014 0.76
105 Real-time multipoint gastrointestinal 19-fluorine catheter tracking. Magn Reson Med 2013 0.76
106 19F MR imaging golden angle-based capsule tracking for intestinal transit and catheter tracking: initial in vivo experience. Radiology 2012 0.76
107 World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015. J Clin Gastroenterol 2016 0.76
108 Patient-controlled analgesia and sedation in gastrointestinal endoscopy. Gastrointest Endosc Clin N Am 2004 0.75
109 Exogenous heat shock protein gp96 ameliorates CD4+CD62L+ T-cell-mediated transfer colitis. Inflamm Bowel Dis 2014 0.75
110 The analysis of gastric volume measurement by SPECT: gastric structure vs. function. Gastroenterology 2005 0.75
111 Use of evidence in WHO recommendations. Lancet 2007 0.75
112 Knock-out of β-glucosidase 2 has no influence on dextran sulfate sodium-induced colitis. Digestion 2011 0.75
113 Anal lesions and suspected sexual abuse in a 17-year-old girl. Swiss Med Wkly 2005 0.75
114 Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease? Eur J Gastroenterol Hepatol 2016 0.75
115 Association between Cogan's syndrome and inflammatory bowel disease: a case series. J Crohns Colitis 2010 0.75
116 A distinct pattern of disease-associated single nucleotide polymorphisms in IBD risk genes in a family with Crohn's disease. Eur J Gastroenterol Hepatol 2014 0.75
117 [Constipation]. Praxis (Bern 1994) 2008 0.75
118 NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22. J Clin Invest 2016 0.75
119 [Highlights in gastroenterology 2010]. Praxis (Bern 1994) 2010 0.75
120 The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort. Digestion 2016 0.75
121 ["When to test for and treat H. pylori"]. Praxis (Bern 1994) 2015 0.75
122 Should PPIs be given to patients on antiplatelet drugs? Nat Clin Pract Gastroenterol Hepatol 2006 0.75